CIP2A- and SETBP1-mediated PP2A inhibition reveals AKT S473 phosphorylation to be a new biomarker in AML (Blood Advances, 2018)

(untitled) - Lucas, C; Scott, L; Carmell, N; Holcroft, A; Hills, R; Burnett, A; Clark, R